TOPMed

Parent/Study Descriptions and Statements

Notes: “phs” is a dbGaP study accession number prefix indicating a phenotype study. A study accession number is a unique, stable, and versioned identifier.
For studies with no description in the table below, click on the phs number to see the summary provided on dbGaP. In the table, you may encounter phs links that redirect to a dbGaP error page. If so, this is because the TOPMed dbGaP study webpages do not go live until the study accession is released.

The table below provides the names of institutions providing ethics approval or oversight so TOPMed authors can respond to journals that require documentation for ethics review of studies involving human subjects.

Is your study missing a description? Contact the TOPMed ACC.

Short Name	Title	TOPMed Accession #	Description	Ethics statement
Sarcoidosis	Genetics of Sarcoidosis in African Americans	phs001207	Sarcoidosis patients, their relatives and unrelated controls were typed using whole genome sequencing to identify genetic variants associated with susceptibility, severity and specific disease manifestation.	All sarcoidosis study participants provided informed consent, and the study was approved by the IRB at the Oklahoma Medical Research Foundation.
SARP	Severe Asthma Research Program	phs001446
SCVI	Stanford Cardiovascular Institute iPSC Biobank Study	phs002338
SIT_SCD	Silent Infarction Transfusion (SIT) Sickle Cell Disease (SCD)	sequencing not planned
SPIROMICS	SubPopulations and InteRmediate Outcome Measures In COPD Study	phs001927
SPIROMICS COPDMet	SubPopulations and InteRmediate Outcome Measures In COPD Study	phs001927
STAGES	Sleep Technology Analytics and Genomics of Sleep
THRV	Taiwan Study of Hypertension using Rare Variants	phs001387		All THRV participants provided informed consent, and the study was approved by the Institutional Review Board at The Lundquist Institute (formerly Los Angeles BioMedical Research Institute) at Harbor-UCLA Medical Center. All THRV participants provided informed consent, and the study was approved by the Institutional Review Board at Washington University in St. Louis.
TOPCHeF	Trans-Omics for Precision Medicine for Congestive Heart Failure	phs002038		All TOPCHeF participants provided informed consent, and the study was approved by the Colorado Multi-Institutional Review Board at the University of Colorado.
UCSF_AF	UCSF_AF	phs001933		All UCSF_AF participants provided informed consent, and the study was approved by the Institutional Review Board of the University of California, San Francisco.